vs
Finward Bancorp(FNWD)与Immunovant, Inc.(IMVT)财务数据对比。点击上方公司名可切换其他公司
Finward Bancorp的季度营收约是Immunovant, Inc.的2.0倍($16.5M vs $8.4M),Finward Bancorp净利率更高(12.0% vs -899.0%,领先911.0%),Immunovant, Inc.同比增速更快(140.7% vs 1.1%),Finward Bancorp自由现金流更多($9.0M vs $-59.8M)
Finward Bancorp是一家总部位于美国的区域性银行控股公司,主要面向本土运营区域内的个人消费者与中小企业,提供储蓄账户、各类贷款、商业融资及财富管理等零售与商业金融服务。
Immunovant是一家临床阶段生物制药企业,专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法,其核心在研候选产品覆盖多种自身免疫适应症,面向全球医疗市场布局研发管线。
FNWD vs IMVT — 直观对比
营收规模更大
FNWD
是对方的2.0倍
$8.4M
营收增速更快
IMVT
高出139.7%
1.1%
净利率更高
FNWD
高出911.0%
-899.0%
自由现金流更多
FNWD
多$68.9M
$-59.8M
损益表 — Q4 FY2025 vs Q4 FY2024
| 指标 | ||
|---|---|---|
| 营收 | $16.5M | $8.4M |
| 净利润 | $2.0M | $-75.3M |
| 毛利率 | — | — |
| 营业利润率 | 11.0% | -896.2% |
| 净利率 | 12.0% | -899.0% |
| 营收同比 | 1.1% | 140.7% |
| 净利润同比 | -5.6% | -26.7% |
| 每股收益(稀释后) | $0.46 | $-0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FNWD
IMVT
| Q4 25 | $16.5M | — | ||
| Q3 25 | $17.4M | — | ||
| Q2 25 | $16.6M | — | ||
| Q1 25 | $15.5M | — | ||
| Q4 24 | $16.3M | — | ||
| Q3 24 | $14.9M | — | ||
| Q2 24 | $14.6M | — | ||
| Q1 24 | $25.3M | $8.4M |
净利润
FNWD
IMVT
| Q4 25 | $2.0M | — | ||
| Q3 25 | $3.5M | — | ||
| Q2 25 | $2.2M | — | ||
| Q1 25 | $455.0K | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $606.0K | — | ||
| Q2 24 | $143.0K | — | ||
| Q1 24 | $9.3M | $-75.3M |
营业利润率
FNWD
IMVT
| Q4 25 | 11.0% | — | ||
| Q3 25 | 20.5% | — | ||
| Q2 25 | 12.7% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 16.3% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 40.6% | -896.2% |
净利率
FNWD
IMVT
| Q4 25 | 12.0% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 12.9% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 12.9% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 36.7% | -899.0% |
每股收益(稀释后)
FNWD
IMVT
| Q4 25 | $0.46 | — | ||
| Q3 25 | $0.81 | — | ||
| Q2 25 | $0.50 | — | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $0.50 | — | ||
| Q3 24 | $0.14 | — | ||
| Q2 24 | $0.03 | — | ||
| Q1 24 | $2.17 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $635.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $174.7M | $617.8M |
| 总资产 | $2.0B | $666.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
FNWD
IMVT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $635.4M |
股东权益
FNWD
IMVT
| Q4 25 | $174.7M | — | ||
| Q3 25 | $165.5M | — | ||
| Q2 25 | $154.3M | — | ||
| Q1 25 | $151.8M | — | ||
| Q4 24 | $151.4M | — | ||
| Q3 24 | $159.6M | — | ||
| Q2 24 | $148.6M | — | ||
| Q1 24 | $151.6M | $617.8M |
总资产
FNWD
IMVT
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — | ||
| Q1 24 | $2.1B | $666.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $9.9M | $-59.7M |
| 自由现金流经营现金流 - 资本支出 | $9.0M | $-59.8M |
| 自由现金流率自由现金流/营收 | 54.8% | -714.4% |
| 资本支出强度资本支出/营收 | 5.2% | 1.8% |
| 现金转化率经营现金流/净利润 | 4.99× | — |
| 过去12个月自由现金流最近4个季度 | $10.6M | $-214.6M |
8季度趋势,按日历期对齐
经营现金流
FNWD
IMVT
| Q4 25 | $9.9M | — | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | $-3.8M | — | ||
| Q4 24 | $9.8M | — | ||
| Q3 24 | $-3.7M | — | ||
| Q2 24 | $2.8M | — | ||
| Q1 24 | $-25.0K | $-59.7M |
自由现金流
FNWD
IMVT
| Q4 25 | $9.0M | — | ||
| Q3 25 | $1.0M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $-4.0M | — | ||
| Q4 24 | $6.7M | — | ||
| Q3 24 | $-4.2M | — | ||
| Q2 24 | $1.1M | — | ||
| Q1 24 | $-736.0K | $-59.8M |
自由现金流率
FNWD
IMVT
| Q4 25 | 54.8% | — | ||
| Q3 25 | 6.0% | — | ||
| Q2 25 | 27.0% | — | ||
| Q1 25 | -25.7% | — | ||
| Q4 24 | 41.2% | — | ||
| Q3 24 | -28.5% | — | ||
| Q2 24 | 7.6% | — | ||
| Q1 24 | -2.9% | -714.4% |
资本支出强度
FNWD
IMVT
| Q4 25 | 5.2% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 18.8% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 11.2% | — | ||
| Q1 24 | 2.8% | 1.8% |
现金转化率
FNWD
IMVT
| Q4 25 | 4.99× | — | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 2.22× | — | ||
| Q1 25 | -8.37× | — | ||
| Q4 24 | 4.66× | — | ||
| Q3 24 | -6.15× | — | ||
| Q2 24 | 19.23× | — | ||
| Q1 24 | -0.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图